Multide emulsion-mediated enhancement of the therapeutic effect of the trandrine against silicosis

Applied Occupational and Environmental Hygiene

Volumn 11, Issue 7, 1996, Pages 1008-1018

  Chao, De Hwa ^a   Ma, Jane Y C ^b   Malanga, Carl J ^a   Banks, Daniel E ^c   Hubbs, Ann F ^b   Rojanasakul, Yongyut ^a   Castranova, Vincent ^b   Ma, Joseph K H ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; SILICON DIOXIDE; TETRANDRINE;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DUST EXPOSURE; EMULSION; HISTOLOGY; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS CELL; LUNG FIBROSIS; MALE; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL LUNG DISEASE; PRIORITY JOURNAL; RAT; SILICOSIS;

EID: 0029812532     PISSN: 1047322X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1047322X.1996.10390003     Document Type: Article

References (45)

1. Freeman, B.A.; Mason, R.J.; Williams, M.C.; Crapo, J.D.: Antioxidant Enzyme Activity in Alveolar Type II Cells after Exposure of Rats to Hyperoxia. Exp. Lung Res 10:203-222 (1986).
2. Adamson, I.Y.; Bowden, D.H.: The Type 2 Cell as Progenitor of Alveolar Epithelial Regeneration: A Cytodynamic Study in Mice after Exposure to Oxygen. Lab. Invest. 30:35-42 (1974).
3. Bowden, D.H.: Alveolar Response to Injury. Thorax 36:801804 (1981).
4. Heppleston, A.G.: Silicotic Fibrogenesis: A Concept of Pulmonary Fibrosis. Ann. Occup. Hyg. 26:449-452 (1982).
5. Davis, G.S.: The Pathogenesis of Silicosis. Chest 89:166S-169S (1986).
6. Castranova, V.; Kang, J.H.; Moore, M.D. et al.: Inhibition of Stimulant-induced Activation of Phagocytic Cells with Tetrandrine. J. Leukocyte Biol. 50:412-422 (1991).
7. Weiss, S.J.; Buglio, A.F.: Biology of Disease: Phagocyte-Generated Oxygen Metabolites and Cellular Injury. Lab. Invest. 47: 5-18 (1982).
8. Borm, P.J.A.; Henderson, P.T.: Symposium on Health Effects of Occupational Exposure to Inorganic Dusts. Exp. Lung Res. 16:1-3 (1990).
9. Welish, M.J.; Shasby, D.M.; Husted, R.M.: Oxidants Increase Paracellular Permeability in a Cultured Epithelial Cell Line. J. Clin. Invest. 76:1155-1168 (1985).
10. Goldring, M.B.; Krane, S.M.: Modulation of Collagen Synthesis in Human Chondrocyte Cultures by Interleukin-1. J. Bone Min. Res. 1(suppl.):56 (1986).
11. Schmidt, J.A.; Oliver, C.N.; Lape-Zuniga, J.L. et al.: Silica- Stimulated Monocytes Release Fibroblast Proliferation Factors Identical to Interleukin-1: A Potential Role for Interleukin-1 in the Pathogenesis of Silicosis. J. Clin. Invest. 73:1462-1472 (1984).
12. Pohlman, T.H.; Stanness, K.A.; Beatty, P.G. et al.: An Endothelial Cell Surface Factor(s) Induced In Vitro by Lipopolysac- charide, Interleukin 1, and Tumor Necrosis Factor-Alpha Increases Neutrophil Adherence by a CDwl 8-Dependent Mechanism. J. Immunol. 136:4548 (1986).
13. Reist, R.H.; Bryner, K.; Wearden, P. et al.: Development of a Bioassay for Pulmonary Cell Production of Fibrogenic Factors. Toxicol. Meth. 1:53-65 (1991).
14. Bitterman, P.B.; Adelberg, S.; Crystal, R.G.: Mechanisms of Pulmonary Fibrosis: Spontaneous Release of Alveolar Macrophage Derived Growth Factor in the Interstitial Lung Disorders. J. Clin. Invest. 72:1801-1813 (1983).
15. Sibille, Y.; Reynolds, H.Y.: Macrophages and Polymorphonuclear Neutrophils in Lung Defense and Injury. Am. Rev. Respir. Dis. 141:471-50 (1990).
16. Martin, T.R.; Altman, L.C.; Albert, R.K.; Henderson, W.R.: Leukotriene B4 Production by the Human Alveolar Macrophages: A Potential Mechanism for Amplifying Inflammation in the Lung. Am. Rev. Respir. Dis. 129:106-111 (1984).
17. Futone, J.C.; Ward, P.A.: Role of Oxygen-Derived Free Radicals and Metabolites in Leukocyte-Dependent Inflammatory Reactions. Am. J. Pathol. 107:397-418 (1982).
18. Banks, D.E.; Cheng, Y.H.; Weber, S.L.; Ma, J.K.H.: Strategies for the Treatment of Pneumoconiosis. In: Occupational Medicine, the Mining Industry, pp. 205-232. Hanley & Belfus, Philadelphia (1993).
19. Goodman, G.B.; Kaplan, P.D.; Stachura, I. et al.: Acute Silicosis Responding to Corticosteroid Therapy. Chest 101:366-370 (1992).
20. Yu, X.F.; Zou, C.Q.; Lim, M.B.: Observation of the Effect of Tetrandrine on Experimental Silicosis of Rats. Ecotoxicol. Environ. Safety 7:306-312 (1983).
21. Mo, C.G.; Yu, X.F.; Zou, C.Q.: Study on Relationship Between Chemical Structure and Biochemical Action of Bisben- zylisoquinoline Alkaloids. J. Hyg. Res 11:118-130 (1982).
22. Huang, T.; Liu, Y.; Zhao, S.; Li, Y.: Changes of Acid-Soluble Collagen from Lungs of Silicotic Rats and Tetrandrine-Treated Silicotic Rats. Acta Biochem. Biophys. Sintca 13:61-68 (1981).
23. Ma, J.K.H.; Mo, C.G.; Malanga, C.J. et al.: Binding of Bisbenzylisoquinoline Alkaloids to Phosphatidylcholine Vesicles and Alveolar Macrophages: Relationship Between Binding Affinity and Antifibrogenic Potential of These Drugs. Exp. Lung Res. 17:1061-1077 (1991).
24. Ma, J.Y.C.; Barger, M.W.; Ma, J.K.H.; Castranova, V.: Inhibition of Respiratory Burst Activity in Alveolar Macrophages by Bisbenzylisoquinoline Alkaloids: Characterization of Drug-Cell Interaction. Exp. Lung Res. 18:829-843 (1992).
25. Castranova, V.; Kang, J.H.; Ma, J.K.H. et al.: Effects of Bisbenzylisoquinoline Alkaloids on Alveolar Macrophages: Correlation Between Binding Affinity, Inhibitory Potentcy, and Antifibrotic Potential. Toxicol. Appl. Pharmacol. 108:242-252 (1991).
26. Kang, J.H.; Lewis, D.M.; Castranova, V. et al.: Inhibitory Action of Tetrandrine on Macrophage Production of Interleukin-1 (IL-l)-like Activity and Thymocyte Proliferation. Exp. Lung Res. 18:715-729 (1992).
27. Lu, X.R.; Li, Q.R.: Clinical Studies of the Therapeutic Effect of Tetrandrine on Silicosis. Chin. J. Ind. Hyg. Occup. Med. 2:106-110 (1983).
28. Li, T.N.; Hu, T.Y.; Zou, C.Q.: Studies of the Chronic Toxicity of Tetrandrine in Dogs. Ecotoxicol. Environ. Safety 6:528-534 (1983).
29. Schroit, A.J.; Hart, I.R.; Madsen, J.; Fidler, I.J.: Selective Delivery of Drugs Encapsulated in Liposomes: Natural Targeting to Macrophages Involved in Various Disease States. J. Biol. Response Mod. 2:97-100 (1983).
30. Florence, A.T.; Omotosho, J.A.; Whateley, T.L.: Multiple w/o/w Emulsions as Drug Vehicles. In: Controlled Release of Drugs: Polymers and Aggregate Systems, pp. 163-184. M. Rosoff, Ed. VCH, New York (1989).
31. Law, T.K.; Whateley, T.L.; Florence, A.T.: Stabilization of W/O/W Multiple Emulsions by Interfacial Complexation of Macromolecules and Nonionic Surfactants. J. Controlled Rel. 3:279-290 (1986).
32. Iso, M.; Shirahase, T.; Haramura, S. et al.: Application of Encapsulated Enzyme as a Continuous Packed-Bed Reactor. J. Microencapsul. 6:285-299 (1989).
33. Miyakawa, T.; Zhang, W.; Uchida, T. et al.: In Vivo Release of Water-Soluble Drug from Stabilized Water-in-Oil-in-Water (w/o/w) Type Multiple Emulsions Following Intravenous Administrations Using Rats. Biol. Pharm. Bull. 16:268-272 (1993).
34. Omotosho, J.A.; Whateley, T.L.; Florence, A.T.: Methotrexate Transport from the Internal Phase of Multiple w/o/w Emulsions. J. Microencapsul. 6:183-192 (1989).
35. Omotosho, J.A.; Florence, A.T.; Whateley, T.L.: Absorption and Lymphatic Uptake of 5-Fluorouracil in the Rat Following Oral Administration of w/o/w Multiple Emulsions. International J. Pharmaceutics 61:51-56 (1990).
36. Chao, D.H.; Peng, X.S.; Rojanasakul, Y.; et al.: Evaluation of a Multiple Emulsion System for Delivery of Tetrandrine to the Lung I. Formulation Stability, Drug Release, and Cellular Activity. Pharm. Res. 7:S-150 (1990).
37. Chao, D.H.; Pan, W.F.; Rojanasakul, Y. et al.: Evaluation of a Multiple Emulsion System for Delivery of Tetrandrine to the Lung II. Emulsion-Mediated Drug Distribution and Activity in Rat Lungs. Pharm. Res. 9:S201 (1992).
38. Matsumoto, S.; Khoda, M.; Murata, S.: Preparation of Liquid Vesicles on the Basis of a Technique for Providing W/O/W Emulsions. J. Colloid Interface Sci. 62:149-157 (1977).
39. Davis, S.S.; Purewal, T.S.; Burbage, A.S.: The Particle Size Analysis ofMultiple Emulsions. J. Pharm. Pharmacol. 28(Suppl.): 60P (1976).
40. Castranova, V.; Bowman, L.; Miles, P.R.; Reasor, M.J.: Toxicity of Metal Ions to Alveolar Macrophages. Am. J. Ind. Med. 1:349-357 (1980).
41. Kivirikko, K.I.; Laitinen, O.; Prockop, D.J.: Modifications of a Specific Assay for Hydroxyproline in Urine. Anal. Biochem. 19:249-255 (1967).
42. Prophet, E.B.; Mills, B.; Arrington, J.B.; Sobin, L.H. Eds. Laboratory Methods. In: Histotechnology, p. 1-279. Armed Forces Institute of Pathology, Washington, DC (1992).
43. Dauber, J.H.; Roseman, M.D.; Pietra, G.G. et al.: Experimental Silicosis: Morphologic and Biochemical Abnormalities Produced by Intratracheal Instillation of Quartz into Guinea Pig Lungs. Am. J. Pathol. 101:595-612 (1980).
44. Heppleston, A.G.: Atypical Reaction to Inhaled Silica. Nature 213:199 (1967).
45. Miller, K.; Dethloff, L.A.; Hook, G.E.R.: Silica-Induced Hypertrophy of Type II Cells in the Lungs of Rats. Lab. Invest. 55:153-163 (1986).